Advancing In Vitro Microfluidic Models for Pressure-Induced Retinal Ganglion Cell Degeneration: Current Insights and...

Area of Science:

• Ophthalmology
• Biomedical Engineering
• Cell Biology

Background:

• Glaucoma causes irreversible blindness via retinal ganglion cell (RGC) loss and optic nerve damage.
• Elevated intraocular pressure (IOP) is a primary driver of RGC degeneration.
• Current in vivo and in vitro models have limitations in controlling biomechanical parameters and physiological relevance.

Purpose of the Study:

• To review current in vitro models for studying pressure-induced RGC degeneration.
• To explore the potential of microfluidic technologies to improve in vitro glaucoma models.
• To advance understanding of the biomechanical factors in IOP-related RGC loss.

Main Methods:

• Literature review of existing in vitro models for glaucoma research.
• Analysis of microfluidic technologies for simulating ocular microenvironments.
• Discussion of methods for precise pressure manipulation in cell culture.

Main Results:

• In vitro models offer experimental control but lack ocular microenvironment complexity.
• Microfluidic systems can provide more physiologically relevant conditions for RGC studies.
• Advancements in pressure control and culture conditions are crucial for model fidelity.

Conclusions:

• Microfluidic technologies show promise for developing advanced in vitro glaucoma models.
• Improved models can enhance the understanding of biomechanical aspects of RGC degeneration.
• This approach may lead to new insights into glaucoma pathophysiology and treatment.